Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-24-115697

Options or other derivatives

  • Chief Medical Officer acquired 18,333 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Patel Naimish Chief Medical Officer 2024-10-16 Grant or award · Stock Option (Right to Buy) +18,333 18,333 D
Loading xslF345X05/ownership.xml…